Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 1, Issue 12
May 9 2017
Issue Cover

Table of Contents

STIMULUS REPORT

Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α
Beatrice Macchi,Emanuela Balestrieri,Caterina Frezza,Sandro Grelli,Elena Valletta,Ambroise Marçais,Francesca Marino-Merlo,Jocelyn Turpin,Charles R. Bangham,Olivier Hermine,Antonio Mastino,Ali Bazarbachi
View Articletitled, Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α
Supplemental data

REVIEW ARTICLES

Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis
Clinical Trials & Observations
François Caron,Darryl P. Leong,Christopher Hillis,Graeme Fraser,Deborah Siegal
View Articletitled, Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis
Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy
Eric J. Vick,Kruti Patel,Philippe Prouet,Mike G. Martin
View Articletitled, Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy

IMMUNOBIOLOGY

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Natalie A. Bezman,Amy Jhatakia,Alper Y. Kearney,Ty Brender,Mark Maurer,Karla Henning,Misty R. Jenkins,Amy J. Rogers,Paul J. Neeson,Alan J. Korman,Michael D. Robbins,Robert F. Graziano
View Articletitled, PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Supplemental data

LYMPHOID NEOPLASIA

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
Clinical Trials & Observations
Sabah Kadri,Jimmy Lee,Carrie Fitzpatrick,Natalie Galanina,Madina Sukhanova,Girish Venkataraman,Shruti Sharma,Brad Long,Kristin Petras,Megan Theissen,Mei Ming,Yuri Kobzev,Wenjun Kang,Ailin Guo,Weige Wang,Nifang Niu,Howard Weiner,Michael Thirman,Wendy Stock,Sonali M. Smith,Chadi Nabhan,Jeremy P. Segal,Pin Lu,Y. Lynn Wang
View Articletitled, Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
Supplemental data
MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods
Clinical Trials & Observations
Mikhail Roshal,Juan A. Flores-Montero,Qi Gao,Maesa Koeber,Jessica Wardrope,Brian G. M. Durie,Ahmet Dogan,Alberto Orfao,Ola Landgren
View Articletitled, MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods
Supplemental data
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia
Laurent Renou,Pierre-Yves Boelle,Caroline Deswarte,Salvatore Spicuglia,Aissa Benyoucef,Julien Calvo,Benjamin Uzan,Mohamed Belhocine,Agata Cieslak,Judith Landman-Parker,Andre Baruchel,Vahid Asnafi,Françoise Pflumio,Paola Ballerini,Irina Naguibneva
View Articletitled, Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors
Ruby H. P. Law,Guojie Wu,Eleanor W. W. Leung,Koushi Hidaka,Adam J. Quek,Tom T. Caradoc-Davies,Devadharshini Jeevarajah,Paul J. Conroy,Nigel M. Kirby,Raymond S. Norton,Yuko Tsuda,James C. Whisstock
View Articletitled, X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors
Supplemental data
Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
Clinical Trials & Observations
Ang Li,Chris Davis,Qian Wu,Shan Li,Madeline F. Kesten,Leona A. Holmberg,Ajay K. Gopal,David A. Garcia
View Articletitled, Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Transcription factor TLX3 and miR-125b are essential players in the development of T-cell acute lymphoblastic leukemia. The graphical model shows their functional link. See the article by Renou et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

Time to revisit reduced-dose radiotherapy for PCNSL?
Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.
Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
Retreatment of multiple myeloma with previously refractory drugs

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals